Entrada Therapeutics, Inc. (TRDA)
NASDAQ·Healthcare·Biotechnology
$4.60
-5.93%
Mkt Cap $274.07M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$14.00
Range $11.00 – $17.00
Implied Upside
+204.3%
Consensus $14.00 vs current $4.60
NASDAQ·Healthcare·Biotechnology
$4.60
-5.93%
Mkt Cap $274.07M
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$14.00
Range $11.00 – $17.00
+204.3%
Consensus $14.00 vs current $4.60